Cited by 19COVID-19 Clinical Research StudiesRespiratory Support and MechanismsSARS-CoV-2 and COVID-19 Research

Coronavirus Disease 2019 (COVID-19) Complicated by Acute Respiratory Distress Syndrome: An Internist’s Perspective

Open access
Ahmed, Taha, Shah, Ronak J, Rahim, Shab E Gul, Flores, Monica, O'Linn, Amy·2020·Cureus

Abstract

A pandemic outbreak of a novel coronavirus disease (COVID-19) that began in Wuhan, China, in December 2019 has spread rapidly to multiple countries. In the United States, the first confirmed case was reported on January 20, 2020, and since then, the number of cases is rising exponentially on a daily basis. We report a case of COVID-19 infection that presented with symptoms suggestive of pneumonia. Due to the major backlog with an immense number of pending tests, it took 48 hours for the result to come back positive, while the patient went into acute respiratory distress syndrome. We provide an internist's perspective of the difficulties encountered in terms of the available management options, as the patient progressively deteriorated on the regular medical floor prompting transfer to the intensive care unit.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7759/cureus.7482

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Severe respiratory symptoms can cause respiratory failure (ARDS), which can lead to death unless promptly managed using ventilation at ICU.

    “As mentioned before, severe respiratory symptoms can cause respiratory failure (ARDS), which can lead to death unless promptly managed using ventilation at ICU [2, 3, 6].”

    From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [3]

    The Case presentation and Discussion describe acute hypoxic respiratory failure progressing to moderate-to-severe ARDS, followed by intubation and mechanical ventilation in the ICU. The Discussion also reports that ARDS can have fatal outcomes. The paper does not establish that prompt ICU ventilation prevents death; the patient remained critically ill with a poor prognosis after ventilation. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The most common clinical presentation of severe COVID-19 is viral pneumonia featuring fever, cough, dyspnoea, hypoxemia, and bilateral infiltrates on chest radiographs.

    “Evidence shows that the most common clinical presentation of severe COVID-19 is viral pneumonia featuring fever, cough, dyspnoea, hypoxemia, and bilateral infiltrates on chest radiographs [2–4].”

    From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [3]

    The Case presentation (page unavailable) describes one patient with cough, shortness of breath, low oxygen saturation, later fever and hypoxia, and bilateral infiltrates on a subsequent chest X-ray. The Discussion (page unavailable) identifies the case as severe COVID-19 and lists severe pneumonia among reported complications. Neither section establishes that this combination is the most common presentation of severe COVID-19; the patient initially denied fever, and the first X-ray showed a right-sided opacity. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • COVID-19 patients rapidly deteriorate to acute respiratory failure.

    “This is because the respiratory problems experienced by patients with COVID-19 significantly differ from other respiratory conditions (e.g., dry cough is common [4, 19]) and COVID-19 patients' rapid deterioration to acute respiratory failure [2–4].”

    From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [3]

    The Case presentation reports that one patient developed acute hypoxic respiratory failure on day 2, and the Conclusions describe deterioration to moderate-to-severe ARDS within 48 hours. This supports rapid deterioration in the reported case, but the paper does not establish that COVID-19 patients generally deteriorate this way. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • In patients with COVID-19, low blood oxygen levels are associated with rapid deterioration to acute respiratory distress or failure, leading to death unless it is managed immediately [2-4].

    “In patients with COVID-19, low blood oxygen levels are associated with rapid deterioration to acute respiratory distress or failure, leading to death unless it is managed immediately [2–4].”

    From Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study (2022) · cites this paper as [3]

    The Case presentation and Conclusions describe one patient whose hypoxia worsened rapidly and who developed respiratory failure and moderate-to-severe ARDS within 48 hours. The paper does not establish this as a general association in patients with COVID-19 or show that death follows unless the condition is managed immediately; the patient remained critically ill in the ICU at the time of reporting. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 13

  1. [1]A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Lancet Chan JFW Yuan S Kok KH 514 523 395 2020 31986261 PMC7159286
  2. [2]Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet Huang C Wang Y Li X 497 506 395 2020 31986264 PMC7159299
  3. [3]Coronaviruses: an overview of their replication and pathogenesis Methods Mol Biol Fehr AR Perlman S 1 23 1282 2015 25720466 PMC4369385
  4. [4]Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment Cureus Hassan S Sheikh FN Jamal S Ezeh JK Akhtar A 7355 12 2020 PMC7170025 32328367
  5. [5]Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Lancet Lu R Zhao X Li J 565 574 395 2020 32007145 PMC7159086
  6. [6]Features, Evaluation and Treatment Coronavirus (COVID-19) Cascella M Rajnik M Cuomo A Dulebohn SC Napoli RD Treasure Island, FL StatPearls Publishing 2020 https://www.ncbi.nlm.nih.gov/books/NBK554776/ 32150360
  7. [7]First case of 2019 novel coronavirus in the United States N Engl J Med Holushue ML DeBolt C Lindquist S 929 936 385 2020 PMC7092802 32004427
  8. [8]A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med Zhu N Zhang D Wang W 727 733 382 2020 31978945 PMC7092803
  9. [9]Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet Chen N Zhou M Dong X Jr 507 513 395 2020 32007143 PMC7135076
  10. [10]Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention [Epub ahead of print] JAMA Wu Z McGoogan JM 2020 32091533
  11. [11]Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises J Hosp Infect Tang JW Li Y Eames I Chan PK Ridgway GL 100 114 64 2006 16916564 PMC7114857
  12. [12]Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury Lancet Russell CD Millar JE Baillie JK 473 475 395 2020 32043983 PMC7134694
  13. [13]Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [Epub ahead of print] JAMA Intern Med Wu C Chen X Cai Y 2020 PMC7070509 32167524

Cited by

Sorted by citations

Authors
Ahmed, T., Shah, R. J., Rahim, S. E. G., Flores, M., & O'Linn, A.
Affiliations
Cleveland Clinic (US)
Corresponding author
Ahmed, Taha
Venue
Cureus
Published
2020-03-31
Volume
12
Issue
3
Pages
e7482-e7482
ISSN
2168-8184 (ISSN-L)
OpenAlex
W3014366255
Cited by
19
References
0
Citations by year
2024: 1 · 2022: 4 · 2021: 5 · 2020: 9
FWCI
0.59
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Cureus (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
COVID-19 pandemic, acute respiratory distress syndrome, pneumonia, ICU transfer, medical management, internist perspective, clinical deterioration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review